Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about a transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.6%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check31 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision history now includes a new revision labeled v3.7.0 and removes the older entry v3.6.6, reflecting an update to the version history.SummaryDifference0.1%

- Check74 days agoChange DetectedNew revision entry v3.6.6 appears in the Record History, replacing the prior v3.6.5. This indicates a software update to the page's interface rather than changes to the study data or content.SummaryDifference0.1%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.